Anne Sempowski Ward

Business address
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300 E, Washington, DC, 20037
Top holdings (ownership)
SPSC and VNDA
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Anne Sempowski Ward has filed 18 SEC EDGAR filings since 28 Oct 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 09 Jun 2025 05 Jun 2025 001-34186
4 Open Document Open Filing FORM 4 15 May 2025 13 May 2025 001-34702
4 Open Document Open Filing 4 21 May 2024 17 May 2024 001-34186
4 Open Document Open Filing FORM 4 20 May 2024 16 May 2024 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION 12 Jun 2023 08 Jun 2023 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION 16 May 2023 12 May 2023 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2022 16 Jun 2022 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION 19 May 2022 17 May 2022 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION 14 Jun 2021 10 Jun 2021 001-34186
4/A Open Document Open Filing FORM 4/A SUBMISSION 25 May 2021 19 May 2021 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION 21 May 2021 19 May 2021 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION 23 Feb 2021 19 Feb 2021 001-34702
4 Open Document Open Filing FORM 4 23 Dec 2020 22 Dec 2020 001-04219
3 Open Document Open Filing FORM 3 SUBMISSION 13 Nov 2020 04 Nov 2020 001-34702
3 Open Document Open Filing FORM 3 14 Oct 2020 09 Oct 2020 001-04219
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jun 2020 11 Jun 2020 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION 28 Oct 2019 28 Oct 2019 001-34186
3 Open Document Open Filing FORM 3 SUBMISSION 28 Oct 2019 28 Oct 2019 001-34186